EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Related to January 2014 Board Meeting, agenda item 8.5.2.1
Proposed policy statement on sustainable and equitable access to medicines
Public spending austerity measures have placed pressure on the systems of medicines pricing and reimbursement across Europe, with impacts for both patients, and the ability of hospital pharmacists to access the most efficacious medicines on behalf of patients.
Added to this, suggested distortions to external reference pricing due to crisis pricing in some European countries, the growth of health technology assessment as a pricing and reimbursement tool, and the emergence of value based pricing and other innovations (e.g. risk sharing agreements), mean that systems of medicines pricing are in the midst of a period of potentially great change across Europe.
Hospital pharmacists and patients are impacted by these changes, and EAHP is being invited for opinion within the debates taking place in Brussels on this question.
However, without a policy statement covering this area, EAHP does not have a mandate from its member to enter discussions or give opinion on behalf of the profession.
The draft statement (v1) below attempts to address this by making a series of simple points on some of the topics subject to debate, namely:
– putting cost burden directly on to the patient should be avoided
– systems should be more transparent
– generic tendering should be used with care and attention in respect of supply chain impacts
It is very much a first draft, with room for expansion and Board Member views are sought in a number of areas (highlighted in yellow).
[r] indicates where reference material will be added in subsequent drafts.
Policy and Advocacy Officer also suggests a period of pre-consultation with members on a draft in advance of the 1 May deadline for GA papers.
FIRST DRAFT OF EAHP STATEMENT ON MEDICINES PRICING
RF comments on first draft here.
**Further to this, the PAO would like to discuss with the Board the potential for short statements on antimicrobial resistance, ehealth/mhealth, both areas of Brussels/EU activity and debate where opportunities exist to profile and promote hospital pharmacy roles (antimicrobial stewardship), other areas of interest (e.g. bedside scanning), and worthwhile notes of caution (e.g. the need for elements of regulation within the ehealth agenda, e,g. health apps and sources of online medicines advice). Vaccination is one other similar area.**
